| |
| |
|
| Insider
Information: |
Jacobs Bruce N. |
| Relationship: |
|
| City: |
Watertown |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
142,351 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
142,351 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kymera Therapeutics, Inc. |
KYMR |
|
2024-03-04 |
142,351 |
2021-03-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-03-04 |
4 |
S |
$41.41 |
$164,664 |
D/D |
(3,934) |
142,351 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
146,285 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-02 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
115,035 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-03-02 |
4 |
AS |
$30.88 |
$42,465 |
D/D |
(1,370) |
104,568 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
23,750 |
105,938 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-10-21 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
81,279 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-10-17 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
71,279 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-05-03 |
4 |
OE |
$2.08 |
$41,600 |
D/D |
20,000 |
60,814 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,300 |
40,814 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-01-14 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
27,514 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-01-12 |
4 |
AS |
$51.21 |
$777,684 |
D/D |
(15,000) |
17,514 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2022-01-12 |
4 |
OE |
$2.08 |
$31,200 |
D/D |
15,000 |
32,514 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-12-03 |
4 |
AS |
$53.31 |
$535,637 |
D/D |
(10,000) |
17,514 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-12-03 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
27,514 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-03 |
4 |
AS |
$60.05 |
$601,180 |
D/D |
(10,000) |
7,256 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-03 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
17,256 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-06-03 |
4 |
AS |
$46.66 |
$468,695 |
D/D |
(10,000) |
7,256 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-06-03 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
17,256 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-04-13 |
4 |
OE |
$2.08 |
$14,560 |
D/D |
7,000 |
7,000 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-15 |
4 |
OE |
$2.08 |
$17,046 |
D/D |
8,195 |
8,195 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-15 |
4 |
AS |
$60.17 |
$493,096 |
D/D |
(8,195) |
0 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-11 |
4 |
AS |
$60.07 |
$108,432 |
D/D |
(1,805) |
0 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-11 |
4 |
OE |
$2.08 |
$3,754 |
D/D |
1,805 |
1,805 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-08 |
4 |
AS |
$50.46 |
$506,470 |
D/D |
(10,000) |
0 |
0 |
- |
|
| KYMR |
Kymera Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-08 |
4 |
OE |
$2.08 |
$20,800 |
D/D |
10,000 |
10,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
